The Patent Finder
CT

C4 Therapeutics, Inc.

First filing 2018
OverviewNotableFeesChangesFamiliesPatent listSources & methods

43 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.

The next term ends in May 2037. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2037
Next term end
25
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Isoindolinone and Indazole Compounds for the Degradation of Egfr (US 11,673,902) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 1 fee due Jan 4, 2027
    The maintenance fee for Compounds for Targeted Degradation of BRD9 (US 11,691,972) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
  • 1 fee due Mar 12, 2027
    The maintenance fee for Cereblon Binders for the Degradation of Ikaros (US 11,753,397) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
  • 2 fees due Apr 17 to 30, 2027 · next Apr 17
  • 1 fee due Nov 12, 2027
    The maintenance fee for Heterocyclic Degronimers for Target Protein Degradation (US 10,646,575) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 4 of the patents on this record were granted since Aug 18, 2026

What they patent

The 5 largest of its 25 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 10,646,575Heterocyclic Degronimers for Target Protein Degradation
In force
 · High confidence
In forceHigh confidence
US 10,660,968Spirocyclic Degronimers for Target Protein Degradation
In force
 · High confidence
In forceHigh confidence
US 10,849,982C3-CARBON Linked Glutarimide Degronimers for Target Protein Degradation
In force
 · High confidence
In forceHigh confidence
US 10,905,768Heterocyclic Degronimers for Target Protein Degradation
In force
 · High confidence
In forceHigh confidence
US 11,185,592Spirocyclic Degronimers for Target Protein Degradation
In force
 · High confidence
In forceHigh confidence
US 12,048,748Spirocyclic Degronimers for Target Protein Degradation
In force
 · High confidence
In forceHigh confidence
US 12,605,450C3-CARBON Linked Glutarimide Degronimers for Target Protein Degradation
In force
 · High confidence
In forceHigh confidence
US 12,048,747Substituted Piperidine Degronimers for Target Protein Degradation
In force
 · High confidence
In forceHigh confidence
US 12,076,405Heterocyclic Degronimers for Target Protein Degradation
In force
 · Medium confidence
In forceMedium confidence
US 12,180,225N/O-Linked Degrons and Degronimers for Protein Degradation
In force
 · High confidence
In forceHigh confidence
10 of 43 patents shown.
Pro members see all 43.
Pro members: see all 43 patents
Also on record, not counted in the 43: 24 applications pending · 7 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited